| |
|
|
Session 97
Poster Presentations Tuberculosis Treatment in the Setting of Antiretroviral Therapy Tuesday 1:30 - 3:30 pm Hall B |
| 783 | Integration of Antiretroviral Therapy into An Existing Tuberculosis Directly Observed Therapy Program in a Resource Constrained Setting (START Study) C Jack*1, G Friedland2, U Lalloo1, W El-Sadr3, S Cassol1, M Murrman3, Q Abdool Karim1, S Abdool Karim1 1N Mandela Sch of Med, Univ of Natal, Durban, South Africa; 2Yale Univ, New Haven, CT; and 3Columbia Univ, New York, NY |
| 784 | Efficacy of Efavirenz 600mg Dose in the ARV Therapy Regimen for HIV Patients Receiving Rifampicin in theTreatment of Tuberculosis D Pedral-Samapio*1, C Alves3, E Netto1, C Brites1, JO Freire1, R Badaro1 1Univ Fed da Bahia, Brazil and 3CREAIDS-Bahia, Brazil |
| 785 | The Concomitant Use of Rifabutin and Efavirenz in HIV/TB Co-infected Patients E. Hollender*1,2, J. J. Stambaugh1,2, D. Ashkin1,2,3, O. Akinlabi1, M. Narita1,2,3 1A G Holley State Tuberculosis Hosp, Lantana, FL; 2Bureau of Tuberculosis and Refugee Hlth, FL; and 3Univ of Miami Sch of Med, FL |